|
ZNF562 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.123500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.570800E-01 |
| Normal-vs-Stage2 |
7.187600E-01 |
| Normal-vs-Stage3 |
1.203570E-03 |
| Normal-vs-Stage4 |
5.920500E-03 |
| Stage1-vs-Stage2 |
8.365400E-01 |
| Stage1-vs-Stage3 |
2.553900E-04 |
| Stage1-vs-Stage4 |
3.119800E-03 |
| Stage2-vs-Stage3 |
4.529600E-02 |
| Stage2-vs-Stage4 |
6.514300E-02 |
| Stage3-vs-Stage4 |
8.720800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.848400E-02 |
| Normal-vs-AfricanAmerican |
1.978000E-02 |
| Normal-vs-Asian |
6.226400E-01 |
| Caucasian-vs-AfricanAmerican |
2.411800E-01 |
| Caucasian-vs-Asian |
3.634600E-01 |
| AfricanAmerican-vs-Asian |
1.215760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.624000E-02 |
| Normal-vs-Female |
5.645600E-01 |
| Male-vs-Female |
4.978400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.018500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.581800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.938000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.764000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.409600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.235400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.727000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.410010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.735000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.551400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.141420E-01 |
| Normal-vs-Grade 2 |
9.855600E-01 |
| Normal-vs-Grade 3 |
1.029660E-02 |
| Normal-vs-Grade 4 |
1.099460E-03 |
| Grade 1-vs-Grade 2 |
1.536240E-01 |
| Grade 1-vs-Grade 3 |
6.520000E-03 |
| Grade 1-vs-Grade 4 |
2.039100E-03 |
| Grade 2-vs-Grade 3 |
7.177600E-04 |
| Grade 2-vs-Grade 4 |
3.755500E-04 |
| Grade 3-vs-Grade 4 |
2.293400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.209600E-01 |
| Normal-vs-ccB subtype |
1.045890E-02 |
| ccA subtype-vs-ccB subtype |
6.30889999999606E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.438800E-01 |
| Normal-vs-N1 |
2.593200E-01 |
| N0-vs-N1 |
3.870000E-01 |
|
|
